Class C07D : HETEROCYCLIC COMPOUNDS
Subclass 203/10: Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by singly bound oxygen atoms
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12247008 | Multi-aziridine compound | Jan 21, 21 | Mar 11, 25 | Covestro (Netherlands) B.V. |
| 12195429 | Cannabinoid derivatives | Jul 10, 20 | Jan 14, 25 | CANOPY GROWTH CORPORATION |
| 12042541 | Lipids and compositions for the delivery of therapeutics | Mar 31, 23 | Jul 23, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 11712476 | Lipids and compositions for the delivery of therapeutics | Jun 24, 21 | Aug 01, 23 | ARBUTUS BIOPHARMA CORPORATION |
| 10995056 | Direct C—H amination and aza-annulation | Jul 11, 17 | May 04, 21 | The Board of Regents of The University of Texas System; William Marsh Rice University; |
| 10835612 | Lipids and compositions for the delivery of therapeutics | Aug 08, 17 | Nov 17, 20 | ARBUTUS BIOPHARMA CORPORATION |
| 10821186 | Lipids and compositions for the delivery of therapeutics | Sep 06, 18 | Nov 03, 20 | ARBUTUS BIOPHARMA CORPORATION |
| 10442782 | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Nov 14, 17 | Oct 15, 19 | CHDI Foundation Inc. |
| 10117941 | Lipids and compositions for the delivery of therapeutics | May 23, 17 | Nov 06, 18 | ARBUTUS BIOPHARMA CORPORATION |
| 10035754 | Cardanol glycidyl ether derivatives | May 01, 15 | Jul 31, 18 | CENTRE DE TECHNOLOGIE MINÉRALE ET DE PLASTURGIE INC. |
| 9822058 | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | Mar 13, 13 | Nov 21, 17 | CHDI FOUNDATION, INC. |
| 9707292 | Lipids and compositions for the delivery of therapeutics | Oct 15, 15 | Jul 18, 17 | ARBUTUS BIOPHARMA CORPORATION |
| 9682139 | Lipids and compositions for the delivery of therapeutics | Feb 24, 15 | Jun 20, 17 | ARBUTUS BIOPHARMA CORPORATION |
| 9365510 | Aziridine bisphenol ethers and related compounds and methods for their use | Apr 16, 13 | Jun 14, 16 | BRITISH COLUMBIA CANCER AGENCY BRANCH, THE UNIVERSITY OF BRITISH COLUMBIA, |
| 9249109 | Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate | Oct 03, 14 | Feb 02, 16 | DONG-A PHARM. CO., LTD. |
| 9187419 | Intermediates of sitagliptin and preparation process thereof | Dec 01, 11 | Nov 17, 15 | Zhejiang Hisoar Pharmaceutical Co., Ltd |
| 8871950 | Process for preparing (+)-polyoxamic acid | Oct 29, 13 | Oct 28, 14 | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0424,105 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | Jun 06, 24 | Dec 26, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 2024/0325,572 | N-HETEROCYCLYL SUBSTITUTED 2-CYANO-3-(NAPHTHALEN-2-YL)ACRYLAMIDE DERIVATIVES AS FLUOROPHORS FOR DETECTION OF AMYLOID AND AMYLOID-LIKE PROTEINS FOR DIAGNOSIS OF NEURODEGENERATIVE DISORDERS | Jul 15, 22 | Oct 03, 24 | Not available |
| 2023/0140,764 | AZIRIDINE FUNCTIONAL COMPOUND | Jan 21, 21 | May 04, 23 | Not available |
| 2023/0127,229 | MULTI-AZIRIDINE COMPOUND | Jan 21, 21 | Apr 27, 23 | Not available |
| 2023/0054,196 | MULTI-AZIRIDINE COMPOUND | Jan 21, 21 | Feb 23, 23 | Not available |
| 2019/0167,800 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | Sep 06, 18 | Jun 06, 19 | ARBUTUS BIOPHARMA CORPORATION |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
